This site uses cookies to provide you with a more responsive and personalized service. By using this site you agree to the Privacy Policy and Terms of Use. Please read our cookie policy for more information on the use of cookies on this website.
Bridging the Gap is a new webinar series focused on cell and gene therapy. Read the recap of the first session featuring Dr. Grupp, a leader in CAR T-cell therapy.
Artificial DNA synthesis, a fundamental tool of synthetic biology, enables scientists to create DNA molecules of virtually any sequence without a template.
Diagnosed with cancer at age five, Emily Whitehead was the first child to receive CAR T-cell therapy in 2011. Now, her family is helping other children.
Manufacturing and distribution of cell and gene therapies relies on stable low temperatures. Explore ways to increase rigor when storing CGT materials.